Product Images Divalproex Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Divalproex Sodium NDC 50090-3616 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a figure related to two studies (Study 1 and Study 2) with the corresponding abbreviations YRS and WIRS. The figure also shows the abbreviations PBO, DVPK, P80, and DVPX. There is a asterisk indicating statistical significance with p<0.05. The text mentions that PBO stands for placebo and DVPX stands for divalproex sodium delayed-release tablets, but it is unclear what the other abbreviations represent. No further information is available to determine the context or purpose of the figure.*
This text appears to be a chart or a graph with an indication of the percentage reduction of the CPS rate for high and low doses. It also provides information about the percentage of patients who show improvement, no change, or worsening. The chart or graph is not available, so we cannot infer more information from it.*
The text describes the mean 4-week migraine rates for two studies, one with placebo and the other with divalproex sodium delayed-release tablets. The mean dose of divalproex sodium delayed-release tablets was 1,087 mg/day in Study 1, and the dose in Study 2 was either 500 or 1,000 mg/day.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.